Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Learn more about how we are Shortening the distance from lab to life® at syneoshealth.com. - PMLiVE
MORRISVILLE, N.C., Oct. 19, 2021 Syneos Health® , the only fully integrated biopharmaceutical solutions organization, will release its third quarter 2021 financial results on Wednesday,.
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix -Linzagolix, an oral GnRH antagonist, is pending regulatory approval in the U.S. and. | October 13, 2021